Seed Wealth Management’s Novo Nordisk NVO Stock Holding History

Seed Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Sell	9,934 -4,710	-32%	-$202K	0.3%	54
2026 Q1	$538K	Buy	14,644 +3,700	+34%	+$175K	0.37%	45
2025 Q4	$557K	Sell	10,944 -2,310	-17%	-$118K	0.38%	44
2025 Q3	$735K	Sell	13,254 -2,696	-17%	-$158K	0.51%	39
2025 Q2	$1.1M	Buy	15,950 +1,920	+14%	+$131K	0.82%	33
2025 Q1	$974K	Buy	14,030 +2,240	+19%	+$185K	0.79%	31
2024 Q4	$1.01M	Hold	11,790	–	–	0.82%	34
2024 Q3	$1.4M	Hold	11,790	–	–	1.12%	20
2024 Q2	$1.68M	Hold	11,790	–	–	1.47%	16
2024 Q1	$1.5M	Hold	11,790	–	–	1.44%	16
2023 Q4	$1.2M	Hold	11,790	–	–	1.21%	21
2023 Q3	$1.07M	Hold	11,790	–	–	1.2%	22
2023 Q2	$954K	Sell	11,790 -70	-0.6%	-$5.72K	1.01%	26
2023 Q1	$944K	Hold	11,860	–	–	1.07%	24
2022 Q4	$803K	Buy	+11,860	New	+$695K	0.92%	24

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Seed Wealth Management's NVO Position: Q2 2026 in Review

Seed Wealth Management reduced its Novo Nordisk (NVO) stake by 32% in Q2 2026, selling an estimated $202K and leaving 9,934 shares worth $476K. The position accounts for 0.3% of the portfolio, ranked #54.

Seed Wealth Management first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.68M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Seed Wealth Management held 9,934 shares of Novo Nordisk worth $476K as of Q2 2026.
Seed Wealth Management sold 4,710 Novo Nordisk shares in Q2 2026, an estimated $202K.
Novo Nordisk made up 0.3% of Seed Wealth Management's portfolio in Q2 2026, its #54 holding.
Seed Wealth Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
Seed Wealth Management's Novo Nordisk position peaked at $1.68M in Q2 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Seed Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.